Table 3.1: Overall survival (OS) and cumulative mortality rates (CMR) for both competing risks concerning.
|
Years |
OS |
CMR tumor specific (95%CI) |
CMR Comorbidity specific (95%CI) |
|
2 |
96.7 |
0.0 (0.0 - 0.0) |
3.3 (1.1 - 5.6) |
|
4 |
89.5 |
0.5 (0.0 - 1.5) |
10.0 (6.0 - 14.0) |
|
6 |
79.6 |
2.6 (0.3 - 4.8) |
17.8 (12.6 - 23.1) |
|
8 |
69.4 |
5.4 (2.1 - 8.6) |
25.2 (19.1 - 31.4) |
|
10 |
60.0 |
8.7 (4.4 - 13.0) |
31.0 (24.4 - 38.1) |
|
12 |
50.9 |
11.3 (6.2 - 16.4) |
37.8 (30.1 - 45.5) |
|
14 |
41.3 |
15.8 (9.3 - 22.2) |
42.9 (34.3 - 51.5) |
|
16 |
31.5 |
15.8 (9.3 - 22.2) |
52.7 (42.6 - 62.9) |
|
18 |
19.2 |
20.5 (11.7 - 29.3) |
60.4 (47.3 - 73.5) |
|
20 |
19.2 |
20.5 (11.7 - 29.3) |
60.4 (47.3 - 73.5) |
therapy. group RPE (20 years).